Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Operating Expenses | 3,628 | 2,400 | 7,239 | 8,151 | 14,990 |
| Operating Income | -3,628 | -2,400 | -7,239 | -8,151 | -14,990 |
| Interest Expense | 120 | 34 | 9 | 41 | 5 |
| Other Income | 1,120 | 287 | 76 | -1,384 | -12,206 |
| Pre-tax Income | -2,628 | -2,147 | -7,172 | -9,576 | -27,201 |
| Income Tax | N/A | N/A | N/A | 133 | N/A |
| Net Income Continuous | -2,628 | -2,147 | -7,172 | -9,709 | -27,201 |
| Minority Interests | -74 | -7 | -273 | N/A | N/A |
| Net Income | $-2,554 | $-2,140 | $-6,899 | $-9,709 | $-27,201 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.08 | -0.13 | -1.00 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.08 | -0.13 | -1.01 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.08 | -0.13 | -1.00 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.08 | -0.13 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.08 | -0.13 | -1.00 |
| EBITDA(a) | $-3,628 | $-2,400 | $-7,225 | $-8,136 | $-14,734 |